Explore
Validate
LearnABIN118055
antibody from antibodies-online
Targeting: ING1
p24ING1c, p33, p33ING1, p33ING1b, p47, p47ING1a
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [7]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN118055 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Inhibitor of Growth Family, Member 1 (ING1) antibody
- Antibody type
- Polyclonal
- Antigen
- This affinity purified antibody was prepared from whole Goat serum produced by repeatedimmunizations with a synthetic peptide corresponding aa 285-296 of Human p33 ING1protein (Inhibitor of growth family, member 1). Remarks: This sequence shows 100% homology to all splice variants for ING1.
- Reactivity
- Human, Mouse, Rat
- Host
- Goat
- Vial size
- 0.1 mg
- Concentration
- 1.0 mg/ml (UVabs. 280 nm)
- Storage
- Store vial at -20°C prior to opening. Dilute only prior to immediate use. For extendedstorage aliquot contents and freeze at -20°C or below. Avoid cycles of freezing and thawing. Shelf life: one year from despatch.
Submitted references p33(ING1) enhances UVB-induced apoptosis in melanoma cells.
Human ING1 proteins differentially regulate histone acetylation.
DNA damage-inducible gene p33ING2 negatively regulates cell proliferation through acetylation of p53.
Adenovirus-mediated transfer of p33ING1 with p53 drastically augments apoptosis in gliomas.
Extension of the replicative life span of human diploid fibroblasts by inhibition of the p33ING1 candidate tumor suppressor.
A novel candidate tumor suppressor, ING1, is involved in the regulation of apoptosis.
Suppression of the novel growth inhibitor p33ING1 promotes neoplastic transformation.
Cheung KJ Jr, Li G
Experimental cell research 2002 Oct 1;279(2):291-8
Experimental cell research 2002 Oct 1;279(2):291-8
Human ING1 proteins differentially regulate histone acetylation.
Vieyra D, Loewith R, Scott M, Bonnefin P, Boisvert FM, Cheema P, Pastyryeva S, Meijer M, Johnston RN, Bazett-Jones DP, McMahon S, Cole MD, Young D, Riabowol K
The Journal of biological chemistry 2002 Aug 16;277(33):29832-9
The Journal of biological chemistry 2002 Aug 16;277(33):29832-9
DNA damage-inducible gene p33ING2 negatively regulates cell proliferation through acetylation of p53.
Nagashima M, Shiseki M, Miura K, Hagiwara K, Linke SP, Pedeux R, Wang XW, Yokota J, Riabowol K, Harris CC
Proceedings of the National Academy of Sciences of the United States of America 2001 Aug 14;98(17):9671-6
Proceedings of the National Academy of Sciences of the United States of America 2001 Aug 14;98(17):9671-6
Adenovirus-mediated transfer of p33ING1 with p53 drastically augments apoptosis in gliomas.
Shinoura N, Muramatsu Y, Nishimura M, Yoshida Y, Saito A, Yokoyama T, Furukawa T, Horii A, Hashimoto M, Asai A, Kirino T, Hamada H
Cancer research 1999 Nov 1;59(21):5521-8
Cancer research 1999 Nov 1;59(21):5521-8
Extension of the replicative life span of human diploid fibroblasts by inhibition of the p33ING1 candidate tumor suppressor.
Garkavtsev I, Riabowol K
Molecular and cellular biology 1997 Apr;17(4):2014-9
Molecular and cellular biology 1997 Apr;17(4):2014-9
A novel candidate tumor suppressor, ING1, is involved in the regulation of apoptosis.
Helbing CC, Veillette C, Riabowol K, Johnston RN, Garkavtsev I
Cancer research 1997 Apr 1;57(7):1255-8
Cancer research 1997 Apr 1;57(7):1255-8
Suppression of the novel growth inhibitor p33ING1 promotes neoplastic transformation.
Garkavtsev I, Kazarov A, Gudkov A, Riabowol K
Nature genetics 1996 Dec;14(4):415-20
Nature genetics 1996 Dec;14(4):415-20
No comments: Submit comment
No validations: Submit validation data